Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the outcome of loop intrauterine contraceptive device and heart-shaped intrauterine balloon for the adjunctive treatment of severe intrauterine adhesions in patients with infertility.


Clinical Trial Description

Intrauterine adhesion, also known as Asherman's syndrome, is the partial or complete occlusion of the uterine cavity as a result of endometrium damage. Most intrauterine adhesions patients manifest amenorrhea, reduced menstrual pattern, infertility, and intrauterine growth restriction, which seriously affect their reproductive health. Currently, hysteroscopy is the preferred method of intrauterine adhesions diagnosis and treatment. However, because intrauterine adhesions patients generally have poor endometrium repair capability, the incidence rate of reformation of intrauterine adhesions ranging from 20%-62.5% in those with severe adhesions. The successful pregnancy rate after treatment in severe Asherman's syndrome is reported to be consistently lower, only 33%. The prevention of intrauterine adhesions recurrence after trans-cervical resection of adhesion is clinically important but difficult. Therefore, this study was conducted. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02708277
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact
Status Completed
Phase N/A
Start date January 2011
Completion date March 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03223454 - Human Amniotic Epithelial Cells for Asherman's Syndrome Phase 1
Terminated NCT02825849 - Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair Phase 2
Recruiting NCT06450301 - Senescent Endometrial Cells in Patients With Thin Endometrial Lining
Completed NCT02144987 - Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy Phase 4